Stereotaxis, Inc. (STXS)
NYSE: STXS · Electromedical & Electrotherapeutic Apparatus · St.Louis, MO · filing with the SEC since 2004
Who owns Stereotaxis, Inc.
As filed with the SECHolders of 5% or more
1
Daniel Louis Kaufman holds 5.9% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G filed Aug 19, 2026 says.
Directors and officers
8
report now, of 23 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Daniel Louis Kaufman
SCHEDULE 13G · filed Aug 19, 2026 · Common Stock, par value $0.001 per share
Lagoda Investment Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.1% in May 15, 2025
What STXS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Access Point Technologies EP Inc
A company bought · acquisition · Jul 2024 · owns, named in the 10-K filed Mar 12, 2026
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 12, 2026.
Insider tradesForm 4
0sales
2purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 25 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Isaac Paul J | director | 0 | $0 | 0 | 2 | $100,000 |